Watch Demo

Romania Antidiabetics Industry Outlook 2022 - 2026

See how Romania Antidiabetics performed compared to key markets such as Germany, France and Italy.

Key Market Indicators

In 2021, the country ranked number 15 in this ranking, Australia came ahead at $126,760,000. China, Germany, and Canada respectively were numbers 2, 3 and 4 in this ranking. Romania's insulin export is projected to hit $7.9 million in 2026, up from $6.8 million in 2021, increasing by an average of 2.5% annually. Over the past two decades, the country's supply has grown by 0.4% each year. Romania ranked 21st in 2021, with Jordan coming in first at $6.8 million. France, Italy, and China placed second, third, and fourth respectively. Imports of insulin to Romania are estimated to reach $146.4 million by 2026, up from $127 million in 2021, growing by an average of 2.5% annually. Since 1997, the country's demand for the product has increased by 9.8% each year. In 2021, Romania was the 15th largest importer, with Australia leading the ranking at $127 million. China, Germany, and Canada placed second, third, and fourth, respectively.

Marketing Banner